Search

Clinical Research

Category

san diego

US FDA accepts Ionis Pharma’s Inotersen NDA for priority review

US FDA accepts Ionis Pharma’s Inotersen NDA for priority review  pharmabiz.comFull coverage http://www.pharmabiz.com/NewsDetails.aspx?aid=106609&sid=2

Advertisements

MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib

MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib  Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/MEI-Pharma-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-CDK-Inhibitor-Voruciclib-1012665778

Pharma giant Pfizer pulls out of research into Alzheimer’s

Pharma giant Pfizer pulls out of research into Alzheimer’s  BBC NewsFull coverage http://www.bbc.co.uk/news/health-42633871

Neurocrine Biosciences Announces Retirement of Christopher O’Brien, MD, and Appointment of Eiry W. Roberts, MD …

Neurocrine Biosciences Announces Retirement of Christopher O’Brien, MD, and Appointment of Eiry W. Roberts, MD …  Markets InsiderCan A Similar Series of Events Expected At Neurocrine Biosciences, Inc. (NBIX), Dean Foods Company (DF)  Post AnalystAs Neurocrine Biosciences INC (NBIX) Stock Value Rose, Shareholder Healthcor Management LP Cut Holding by …  BZ WeeklyFull coverage http://markets.businessinsider.com/news/stocks/Neurocrine-Biosciences-Announces-Retirement-of-Christopher-O-Brien-M-D-and-Appointment-of-Eiry-W-Roberts-M-D-as-Chief-Medical-Officer-1012626025

Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the JP Morgan 36th Annual Healthcare …

Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the JP Morgan 36th Annual Healthcare …  Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/Amplyx-Pharmaceuticals-Announces-Appointment-of-CFO-and-Presentation-at-the-J-P-Morgan-36th-Annual-Healthcare-Conference-1012663034

BRIEF-Beigene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific …

BRIEF-Beigene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific …  ReutersFull coverage https://uk.reuters.com/article/brief-beigene-and-mirati-therapeutics-an/brief-beigene-and-mirati-therapeutics-announce-exclusive-license-agreement-for-sitravatinib-in-the-asia-pacific-region-idUKFWN1P30HN

Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary …

Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary …  PR Newswire (press release)Full coverage https://www.prnewswire.com/news-releases/avelas-biosciences-completes-period-1-patient-enrollment-in-phase-2-study-of-avb-620-in-women-with-primary-nonrecurrent-breast-cancer-undergoing-surgery-300577505.html

BRIEF-Pfenex Names Susan A. Knudson As Chief Financial Officer

BRIEF-Pfenex Names Susan A. Knudson As Chief Financial Officer  ReutersFull coverage https://www.reuters.com/article/brief-pfenex-names-susan-a-knudson-as-ch/brief-pfenex-names-susan-a-knudson-as-chief-financial-officer-idUSASB0BZQX

Avelas Biosciences Broadens Management Team with Key Executive Additions

Avelas Biosciences Broadens Management Team with Key Executive Additions  NB HerardFull coverage https://nbherard.com/business/avelas-biosciences-broadens-management-team-with-key-executive-additions/48119

Blog at WordPress.com.

Up ↑

%d bloggers like this: